Physician profile
Nickolas Baker
NPI 1275983736
$6,536.19
in general payments reported to CMS, 2019-2025
34 companies · $1,859 in 2025
The $1,859 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,398 · 2023: $1,862 · 2024: $1,418 · 2025: $1,859.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,138.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,532.85 | 2022-2025 | Vraylar, Qulipta, Linzess |
| Novo Nordisk INC | $850.75 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $765.39 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $366.34 | 2022-2025 | Freestyle Libre 3 |
| Pfizer INC. | $328.52 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $312.37 | 2023-2025 | Airsupra, Farxiga |
| Corcept Therapeutics | $282.51 | 2025 | Korlym |
| Antares Pharma, INC. | $253.09 | 2022-2025 | Xyosted |
| Exact Sciences Corporation | $245.10 | 2024-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $231.61 | 2022-2025 | Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $172.72 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $168.78 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $161.85 | 2022-2024 | Rexulti |
| Dexcom, INC. | $143.26 | 2023-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $126.53 | 2023-2025 | Repatha, Krystexxa |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $62.80 | 2023-2025 | Veozah |
| Halozyme INC | $58.39 | 2023 | |
| Noven Therapeutics, LLC | $58.08 | 2024-2025 | Xelstrym |
| Corium, LLC | $48.80 | 2023 | Azstarys |
| Sanofi-Aventis U.S. LLC | $42.88 | 2022-2025 | |
| Tolmar, INC. | $41.32 | 2025 | Jatenzo |
| Mannkind Corporation | $39.29 | 2022 | |
| Currax Pharmaceuticals LLC | $32.72 | 2023-2025 | Contrave |
| Si-Bone, INC. | $27.78 | 2025 | |
| Phathom Pharmaceuticals, INC. | $26.48 | 2025 | Voquezna |
| Medtronic, INC. | $22.52 | 2025 | Venaseal |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.27 | 2024 | Xifaxan, Trulance |
| Intra-Sana Laboratories | $19.82 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Seqirus USA INC | $18.15 | 2024 | Flucelvax, Fluad |
| Horizon Therapeutics Plc | $16.92 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.16 | 2022 | |
| Idorsia Pharmaceuticals US INC | $15.14 | 2024 | Quviviq |
| Arbor Pharmaceuticals, INC. | $14.24 | 2022 | |
| Collegium Pharmaceutical, INC. | $12.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nickolas Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.